glp 1 tirzepatide mounjaro Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute GLP-1 receptor agonists like semaglutide

FDA commissioner Marty Makary announced a clamp down on illegal GLP-1RA compounders in October 2025.

These encompass anxiety levels, exploratory tendencies, spatial memory, stress responses, and intricate movement patterns 11,12

And for people with no prior substance use disorder, did GLP-1 drugs reduce their risk of developing one across all major addictive substances: alcohol, opioids, cocaine, cannabis and nicotine

Qual Life Res

For some patients, weight regain despite intensive lifestyle efforts may warrant consideration of resuming tirzepatide or transitioning to alternative anti-obesity medications, provided they meet FDA-indicated criteria (BMI 30 kg/m or 27 kg/m with weight-related comorbidity)